ANCARON Side Effects

7018562-7 | Pneumonia
on Sep 16, 2010 Male patient from JAPAN , 76 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cardiac failure and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Ancaron dosage: . During the same period patient was treated with ALLOPURINOL (Dose And Frequency Not Specified) (View Allopurinol Review and Allopurinol Label ), PROTECADIN (Dose And Frequency Not Specified) (View Protecadin Review and Protecadin Label ), MICARDIS (Dose And Frequency Not Specified) (View Micardis Review and Micardis Label ), COROHERSER (Dose And Frequency Not Specified) (View Coroherser Review and Coroherser Label ), TORASEMIDE (Dose And Frequency Not Specified) (View Torasemide Review and Torasemide Label ), ASPIRIN (Dose And Frequency Not Specified) (View Aspirin Review and Aspirin Label ), WARFARIN (Dose And Frequency Not Specified) (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

7017856-9 | Atrial Fibrillation, Atrial Flutter, Bradycardia, Cardiogenic Shock, Loss Of Consciousness, Pneumonia, Respiratory Rate Increased, Syncope, Ventricular Fibrillation
Patient was taking Ancaron (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), atrial flutter, bradycardia, cardiogenic shock, loss of consciousness, pneumonia (What is pneumonia?), respiratory rate increased, syncope, ventricular fibrillation on Sep 08, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, weighting 153.2 lb, was diagnosed with atrial tachycardia, pneumonia (What is pneumonia?) and. Ancaron dosage: . During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), GENINAX (400 Mg) (View Geninax Review and Geninax Label ), RENIVACE (View Renivace Review and Renivace Label ), LASIX (View Lasix Review and Lasix Label ), FLUTICASONE PROPIONATE/SALMETEROL XINAFOATE (View Fluticasone Propionate/salmeterol Xinafoate Review and Fluticasone Propionate/salmeterol Xinafoate Label ), WARFARIN (View Warfarin Review and Warfarin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6931045-5 | Maculopathy
Adverse event was reported on Aug 11, 2010 by a Female patient taking Ancaron (View Usage) (Dosage: Dose And Frequency Not Specified) . Location: JAPAN , 70 years of age, After Ancaron was administered, patient had the following side effects: maculopathy.

6836762-3 | Hypernatraemia
on Jul 05, 2010 Male patient from JAPAN , 65 years of age, weighting 97.00 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), ventricular arrhythmia and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: hypernatraemia. Ancaron dosage: . During the same period patient was treated with ARTIST (Dose Not Provided) (View Artist Review and Artist Label ), MEXITIL (Dose Not Provided) (View Mexitil Review and Mexitil Label ), THYRADIN S (Dose Not Provided) (View Thyradin S Review and Thyradin S Label ), LANSOPRAZOLE (Dose Not Provided) (View Lansoprazole Review and Lansoprazole Label ), CAPTOPRIL (Dose Not Provided) (View Captopril Review and Captopril Label ), ALDACTONE (Dose Not Provided) (View Aldactone Review and Aldactone Label ). Patient was hospitalized.


6791195-3 | Acute Respiratory Distress Syndrome, Hepatic Function Abnormal, Interstitial Lung Disease
on Jun 17, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). Patient had the following side effects: acute respiratory distress syndrome, hepatic function abnormal, interstitial lung disease. Ancaron dosage: . During the same period patient was treated with PAZUCROSS (View Pazucross Review and Pazucross Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), INOVAN (View Inovan Review and Inovan Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), HEPARIN (View Heparin Review and Heparin Label ), HANP (View Hanp Review and Hanp Label ). Patient was hospitalized.

6786981-X | Hypernatraemia
Patient was taking Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: hypernatraemia on Jun 15, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, weighting 97.00 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), ventricular arrhythmia and. Ancaron dosage: . During the same period patient was treated with ARTIST (Dose Not Provided) (View Artist Review and Artist Label ), MEXITIL (Dose Not Provided) (View Mexitil Review and Mexitil Label ), THYRADIN S (Dose Not Provided) (View Thyradin S Review and Thyradin S Label ), LANSOPRAZOLE (Dose Not Provided) (View Lansoprazole Review and Lansoprazole Label ), CAPTOPRIL (Dose Not Provided) (View Captopril Review and Captopril Label ), ALDACTONE (Dose Not Provided) (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6774001-2 | Cardiac Failure, Cell Marker Increased, Condition Aggravated
Adverse event was reported on Jun 07, 2010 by a Female patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with arrhythmia prophylaxis, atrial tachycardia and. Location: FRANCE , 73 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, cell marker increased, condition aggravated. During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIART (View Diart Review and Diart Label ), ARTIST (View Artist Review and Artist Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PARIET (View Pariet Review and Pariet Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6754642-9 | Hypernatraemia
on May 25, 2010 Male patient from JAPAN , 65 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Ancaron (View Usage). Patient had the following side effects: hypernatraemia. Ancaron dosage: . During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CAPTOPRIL (View Captopril Review and Captopril Label ).

6706634-3 | Acute Respiratory Distress Syndrome, Bacterial Infection, Cardiac Failure Chronic, Cell Marker Increased, Condition Aggravated, Disseminated Intravascular Coagulation, Hypophagia, Interstitial Lung Disease
on Apr 21, 2010 Male patient from JAPAN , 85 years of age, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: acute respiratory distress syndrome, bacterial infection (What is bacterial infection?), cardiac failure chronic, cell marker increased, condition aggravated, disseminated intravascular coagulation, hypophagia, interstitial lung disease. Ancaron dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), TAKEPRON (View Takepron Review and Takepron Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ). Patient was hospitalized.

6644063-1 | Hypothyroidism, Sick Sinus Syndrome
Patient was taking Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: hypothyroidism, sick sinus syndrome on Mar 12, 2010 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), atrial flutter and. Ancaron dosage: .

6637991-4 | Interstitial Lung Disease, Pancreatitis, Pseudomembranous Colitis, Renal Failure
Adverse event was reported on Mar 08, 2010 by a Male patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , 79 years of age, Patient had the following side effects: interstitial lung disease, pancreatitis, pseudomembranous colitis, renal failure. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6636957-8 | Acute Respiratory Distress Syndrome, Cardiac Failure Congestive, Condition Aggravated, Hepatic Function Abnormal, Interstitial Lung Disease, Renal Failure
on Mar 08, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: acute respiratory distress syndrome, cardiac failure congestive, condition aggravated, hepatic function abnormal, interstitial lung disease, renal failure. Ancaron dosage: . During the same period patient was treated with PAZUCROSS (View Pazucross Review and Pazucross Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), INOVAN (View Inovan Review and Inovan Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), HEPARIN (View Heparin Review and Heparin Label ), HANP (View Hanp Review and Hanp Label ). Patient was hospitalized.

6619087-0 | Interstitial Lung Disease, Pancreatitis
on Mar 01, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pancreatitis. Ancaron dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6619086-9 | Disseminated Intravascular Coagulation, Interstitial Lung Disease, Liver Disorder, Pneumonia Fungal, Pneumonia Viral
Patient was taking Ancaron (View Usage). Patient had the following side effects: disseminated intravascular coagulation, interstitial lung disease, liver disorder, pneumonia fungal, pneumonia viral on Mar 02, 2010 from JAPAN Additional patient health information: Male patient , 81 years of age, weighting 114.6 lb, was diagnosed with ventricular tachycardia, ventricular fibrillation, diabetes mellitus and. Ancaron dosage: . During the same period patient was treated with BASEN (View Basen Review and Basen Label ), ARTIST (View Artist Review and Artist Label ), CONIEL (View Coniel Review and Coniel Label ), ITOROL (View Itorol Review and Itorol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (View Pariet Review and Pariet Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ).

6618892-4 | Bone Marrow Failure, Cytomegalovirus Infection, Endocarditis Candida, Pancytopenia, Renal Failure
Adverse event was reported on Feb 24, 2010 by a Male patient taking Ancaron (View Usage) (Dosage: ) . Location: FRANCE , 83 years of age, After Ancaron was administered, patient had the following side effects: bone marrow failure, cytomegalovirus infection (What is cytomegalovirus infection?), endocarditis candida, pancytopenia, renal failure. During the same period patient was treated with PANALDINE (View Panaldine Review and Panaldine Label ). Patient was hospitalized.

6613512-7 | Acute Myocardial Infarction, Disseminated Intravascular Coagulation, Hepatic Cirrhosis, Hypoglycaemia, Infection Susceptibility Increased, Interstitial Lung Disease, Liver Disorder, Opportunistic Infection, Pneumonia Fungal
on Feb 23, 2010 Male patient from JAPAN , 81 years of age, weighting 114.6 lb, was diagnosed with ventricular tachycardia, ventricular fibrillation, diabetes mellitus and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, disseminated intravascular coagulation, hepatic cirrhosis, hypoglycaemia, infection susceptibility increased, interstitial lung disease, liver disorder, opportunistic infection, pneumonia fungal. Ancaron dosage: . During the same period patient was treated with BASEN (View Basen Review and Basen Label ), ARTIST (View Artist Review and Artist Label ), CONIEL (View Coniel Review and Coniel Label ), ITOROL (View Itorol Review and Itorol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (View Pariet Review and Pariet Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ).

6612510-7 | Acute Respiratory Distress Syndrome, Cardiac Failure Congestive, Condition Aggravated, Hepatic Function Abnormal, Interstitial Lung Disease, Renal Failure
on Feb 23, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). Patient had the following side effects: acute respiratory distress syndrome, cardiac failure congestive, condition aggravated, hepatic function abnormal, interstitial lung disease, renal failure. Ancaron dosage: . During the same period patient was treated with PAZUCROSS (View Pazucross Review and Pazucross Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), INOVAN (View Inovan Review and Inovan Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), HEPARIN (View Heparin Review and Heparin Label ), HANP (View Hanp Review and Hanp Label ). Patient was hospitalized.

6611815-3 | Hepatitis Fulminant, Multi-organ Failure
Patient was taking Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: hepatitis fulminant, multi-organ failure on Feb 19, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with hypertrophic cardiomyopathy, ventricular tachycardia and. Ancaron dosage: . During the same period patient was treated with GENINAX (^200 Mg 2 T/1m^) (View Geninax Review and Geninax Label ), LIDOCAINE (^1% Drip Infusion 6 Ml/h^) (View Lidocaine Review and Lidocaine Label ), INOVAN (150 Mg 2 Ml/h) (View Inovan Review and Inovan Label ), ARTIST (^2.5 Mg, 0.5 T At Morning^) (View Artist Review and Artist Label ), LEBENIN (View Lebenin Review and Lebenin Label ), ZITHROMAX (^2 G On 2 Hours After Dinner^) (View Zithromax Review and Zithromax Label ), LASIX (^20 Mg 1a^) (View Lasix Review and Lasix Label ).

6591088-0 | Aspergillosis, Cerebral Infarction, Pulmonary Alveolar Haemorrhage
Adverse event was reported on Feb 10, 2010 by a Female patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , 74 years of age, Patient experienced the following unwanted or unexpected effects: aspergillosis, cerebral infarction, pulmonary alveolar haemorrhage. During the same period patient was treated with HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ), VASOLAN (View Vasolan Review and Vasolan Label ), MEVALOTIN (Dose Unkown) (View Mevalotin Review and Mevalotin Label ), FRANDOL (View Frandol Review and Frandol Label ), BLOPRESS (View Blopress Review and Blopress Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6582988-6 | Hyperthyroidism, Pulmonary Fibrosis
on Feb 05, 2010 Male patient from FRANCE , 73 years of age, weighting 134.5 lb, was diagnosed with ventricular fibrillation, ventricular tachycardia and was treated with Ancaron (View Usage). Patient had the following side effects: hyperthyroidism, pulmonary fibrosis (What is pulmonary fibrosis?). Ancaron dosage: Variable Dose, ^increased And Decreased Because The Patient Frequently Developed Vt^.

6569996-6 | Granulocytopenia, Multi-organ Failure, Myocardial Infarction
on Jan 25, 2010 Male patient from JAPAN , 70 years of age, weighting 132.3 lb, was diagnosed with ventricular fibrillation, gastric ulcer, epilepsy (What is epilepsy?), pneumonia (What is pneumonia?), myocardial infarction, coronary arterial stent insertion and was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: granulocytopenia, multi-organ failure, myocardial infarction. Ancaron dosage: . During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), MEROPEN (View Meropen Review and Meropen Label ), ASPIRIN (Dose And Frequency Not Specified) (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6566488-5 | Cardiac Failure, Cell Marker Increased, Condition Aggravated
Patient was taking Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cell marker increased, condition aggravated on Jan 22, 2010 from FRANCE Additional patient health information: Female patient , 73 years of age, was diagnosed with arrhythmia prophylaxis, atrial tachycardia and. Ancaron dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIART (View Diart Review and Diart Label ), ARTIST (View Artist Review and Artist Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PARIET (View Pariet Review and Pariet Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6566379-X | Cardiac Failure, Condition Aggravated, Hypothyroidism
Adverse event was reported on Jan 26, 2010 by a Female patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: JAPAN , 90 years of age, Patient had the following side effects: cardiac failure, condition aggravated, hypothyroidism.

6559110-5 | Aspergillosis, Cerebral Infarction, Pulmonary Alveolar Haemorrhage
on Jan 21, 2010 Female patient from FRANCE , 74 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: aspergillosis, cerebral infarction, pulmonary alveolar haemorrhage. Ancaron dosage: . During the same period patient was treated with HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ), VASOLAN (View Vasolan Review and Vasolan Label ), MEVALOTIN (Dose Unkown) (View Mevalotin Review and Mevalotin Label ), FRANDOL (View Frandol Review and Frandol Label ), BLOPRESS (View Blopress Review and Blopress Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

6557710-X | Granulocytopenia, Multi-organ Failure
on Jan 25, 2010 Male patient from JAPAN , 70 years of age, weighting 132.3 lb, was diagnosed with ventricular fibrillation, myocardial infarction, pneumonia (What is pneumonia?), gastric ulcer and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, multi-organ failure. Ancaron dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), MEROPEN (View Meropen Review and Meropen Label ), GASTER D (View Gaster D Review and Gaster D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6549827-0 | Cardiac Failure Congestive, Condition Aggravated
Patient was taking Ancaron (View Usage). Patient had the following side effects: cardiac failure congestive, condition aggravated on Jan 13, 2010 from JAPAN Additional patient health information: Male patient , 87 years of age, weighting 121.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Ancaron dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), VASOLAN (View Vasolan Review and Vasolan Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ).

6547312-3 | Cardiac Failure, Cerebral Infarction
Adverse event was reported on Jan 13, 2010 by a Female patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with ventricular tachycardia and. Location: JAPAN , 81 years of age, weighting 116.8 lb, After Ancaron was administered, patient had the following side effects: cardiac failure, cerebral infarction. During the same period patient was treated with FRANDOL (View Frandol Review and Frandol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM POLYSTYRENE SULFONATE (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ).

6546923-9 | Granulocytopenia, Hepatic Function Abnormal, Jaundice, Multi-organ Failure
on Jan 06, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with ventricular fibrillation, myocardial infarction, pneumonia (What is pneumonia?), gastric ulcer and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, hepatic function abnormal, jaundice (What is jaundice?), multi-organ failure. Ancaron dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), MEROPEN (View Meropen Review and Meropen Label ), GASTER D (View Gaster D Review and Gaster D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6541914-6 | Lung Disorder
on Jan 08, 2010 Male patient from FRANCE , 68 years of age, weighting 130.1 lb, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). Patient had the following side effects: lung disorder. Ancaron dosage: 400 Mg Daily. During the same period patient was treated with ASPIRIN (Dose And Frequency Not Specified) (View Aspirin Review and Aspirin Label ), WARFARIN (Dose And Frequency Not Specified) (View Warfarin Review and Warfarin Label ), RENIVACE (Dose And Frequency Not Specified) (View Renivace Review and Renivace Label ). Patient was hospitalized.

6538138-5 | Granulocytopenia, Hepatic Function Abnormal, Multi-organ Failure
Patient was taking Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: granulocytopenia, hepatic function abnormal, multi-organ failure on Jan 06, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with ventricular fibrillation, gastric ulcer, epilepsy (What is epilepsy?), pneumonia (What is pneumonia?), myocardial infarction, coronary arterial stent insertion and. Ancaron dosage: . During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), MEROPEN (View Meropen Review and Meropen Label ), ASPIRIN (Dose And Frequency Not Specified) (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6506895-X |
Adverse event was reported on Dec 10, 2009 by a Female patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with ventricular tachycardia and. Location: JAPAN , 54 years of age, . During the same period patient was treated with RENIVACE (View Renivace Review and Renivace Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6504900-8 |
on Dec 08, 2009 Female patient from JAPAN , 81 years of age, weighting 116.8 lb, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). . Ancaron dosage: . During the same period patient was treated with FRANDOL (View Frandol Review and Frandol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM POLYSTYRENE SULFONATE (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ).

6504150-5 |
on Dec 08, 2009 Male patient from JAPAN , 87 years of age, weighting 121.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Ancaron (View Usage). . Ancaron dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), VASOLAN (View Vasolan Review and Vasolan Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ).

6500151-1 | Lung Disorder
Patient was taking Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder on Dec 09, 2009 from FRANCE Additional patient health information: Male patient , 69 years of age, was diagnosed with ventricular tachycardia and. Ancaron dosage: Dose And Frequency Not Specified.

6480841-X | Atrial Fibrillation, Cardiac Failure, Condition Aggravated, Hepatitis Fulminant, Multi-organ Failure, Ventricular Tachycardia
Adverse event was reported on Nov 27, 2009 by a Female patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with ventricular tachycardia and. Location: JAPAN , 70 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, condition aggravated, hepatitis fulminant, multi-organ failure, ventricular tachycardia. During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), COVERSYL (View Coversyl Review and Coversyl Label ), ARTIST (View Artist Review and Artist Label ), PLAVIX (View Plavix Review and Plavix Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6465175-1 | Asthma, Atrial Fibrillation, Cardiac Arrest, Cardiac Failure, Cerebral Infarction, Hepatitis Fulminant, Multi-organ Failure, Upper Respiratory Tract Inflammation
on Nov 20, 2009 Female patient from JAPAN , 70 years of age, was diagnosed with ventricular tachycardia and was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: asthma (What is asthma?), atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), cardiac failure, cerebral infarction, hepatitis fulminant, multi-organ failure, upper respiratory tract inflammation. Ancaron dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6436510-5 | Aspergillosis, Cerebral Infarction, Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
on Nov 04, 2009 Female patient from FRANCE , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, cerebral infarction, interstitial lung disease, pulmonary alveolar haemorrhage. Ancaron dosage: .

6367280-7 | Interstitial Lung Disease
Patient was taking Ancaron (View Usage). Patient had the following side effects: interstitial lung disease on Sep 10, 2009 from JAPAN Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with ventricular tachycardia, cardiac failure, hyperlipidaemia and. Ancaron dosage: . During the same period patient was treated with PURSENNID (View Pursennid Review and Pursennid Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), BLOPRESS (View Blopress Review and Blopress Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), LASIX (View Lasix Review and Lasix Label ), ARTIST (View Artist Review and Artist Label ), RENIVACE (View Renivace Review and Renivace Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6335436-5 | Interstitial Lung Disease, Pneumonia Cytomegaloviral
Adverse event was reported on Aug 20, 2009 by a Male patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with arrhythmia (What is arrhythmia?), vitamin d deficiency, prophylaxis against gastrointestinal ulcer, hyperphosphataemia, constipation (What is constipation?), insomnia, depressed mood, cerebellar infarction and. Location: JAPAN , 75 years of age, After Ancaron was administered, patient had the following side effects: interstitial lung disease, pneumonia cytomegaloviral. During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), SELBEX (View Selbex Review and Selbex Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), SENNARIDE (View Sennaride Review and Sennaride Label ), HALCION (View Halcion Review and Halcion Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ), RADICUT (View Radicut Review and Radicut Label ).

6210011-1 | Hypothyroidism, Sick Sinus Syndrome
on May 20, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), atrial flutter and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: hypothyroidism, sick sinus syndrome. Ancaron dosage: .

6197019-X |
on May 12, 2009 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with ventricular fibrillation and was treated with Ancaron (View Usage). . Ancaron dosage: . During the same period patient was treated with SHINBIT (View Shinbit Review and Shinbit Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ARICEPT (View Aricept Review and Aricept Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PANALDINE (View Panaldine Review and Panaldine Label ), PURSENNID (View Pursennid Review and Pursennid Label ).

6193095-9 | Cardiac Failure, Hepatic Function Abnormal
Patient was taking Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: cardiac failure, hepatic function abnormal on May 08, 2009 from JAPAN Additional patient health information: Male patient , 52 years of age, was diagnosed with congestive cardiomyopathy, arrhythmia (What is arrhythmia?) and. Ancaron dosage: 200-300 Mg/day.

6192196-9 |
Adverse event was reported on May 12, 2009 by a Male patient taking Ancaron (View Usage) (Dosage: ) was diagnosed with ventricular fibrillation and. Location: JAPAN , weighting 121.3 lb, . During the same period patient was treated with SHINBIT (50 Mg In One Day) (View Shinbit Review and Shinbit Label ), LIDOCAINE (40 Mg In One Day) (View Lidocaine Review and Lidocaine Label ), DOGMATYL (50 Mg, Frequency Not Specified) (View Dogmatyl Review and Dogmatyl Label ), WARFARIN SODIUM (2 Mg, Frequency Not Specified) (View Warfarin Sodium Review and Warfarin Sodium Label ), ARICEPT (3 Mg, Frequency Not Specified) (View Aricept Review and Aricept Label ), LIPITOR (10 Mg, Frequency Not Specified) (View Lipitor Review and Lipitor Label ), PANALDINE (200 Mg, Frequency Not Specified) (View Panaldine Review and Panaldine Label ), PURSENNID (36 Mg, Frequency Not Specified) (View Pursennid Review and Pursennid Label ).

6156234-1 | Anaemia, Atrial Fibrillation, Bradycardia, Condition Aggravated, Pneumonia, Ventricular Tachycardia
on Feb 12, 2009 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with ventricular tachycardia, gastric ulcer and was treated with Ancaron (View Usage). Patient had the following side effects: anaemia, atrial fibrillation (What is atrial fibrillation?), bradycardia, condition aggravated, pneumonia (What is pneumonia?), ventricular tachycardia. Ancaron dosage: . During the same period patient was treated with LIDOCAINE HCL IN PLASTIC CONTAINER (View Lidocaine Hcl In Plastic Container Review and Lidocaine Hcl In Plastic Container Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANALDINE (View Panaldine Review and Panaldine Label ), TAKEPRON (View Takepron Review and Takepron Label ), ARTIST (View Artist Review and Artist Label ).

6155956-6 | Interstitial Lung Disease
on Apr 07, 2009 Male patient from JAPAN , 75 years of age, was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: interstitial lung disease. Ancaron dosage: . During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), SELBEX (View Selbex Review and Selbex Label ), SIGMART (View Sigmart Review and Sigmart Label ), LACTOBACILLUS BIFIDUS, LYOPHILIZED (View Lactobacillus Bifidus, Lyophilized Review and Lactobacillus Bifidus, Lyophilized Label ), PANALDINE (View Panaldine Review and Panaldine Label ), ALLEGRA (View Allegra Review and Allegra Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NYCLIN (View Nyclin Review and Nyclin Label ).

6142823-7 | Bradycardia, Cardiac Failure, Ventricular Fibrillation
Patient was taking Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac failure, ventricular fibrillation on Mar 25, 2009 from FRANCE Additional patient health information: Male patient , weighting 121.3 lb, was diagnosed with arrhythmia (What is arrhythmia?) and. Ancaron dosage: . During the same period patient was treated with TORASEMIDE (View Torasemide Review and Torasemide Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ACARDI (View Acardi Review and Acardi Label ), TANATRIL (View Tanatril Review and Tanatril Label ), ARTIST (View Artist Review and Artist Label ), SELBEX (View Selbex Review and Selbex Label ).

6110429-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Bilirubin Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, White Blood Cell Count Increased
Adverse event was reported on Mar 02, 2009 by a Female patient taking Ancaron (View Usage) (Dosage: 17 Ml/hr) was diagnosed with ventricular tachycardia and. Location: JAPAN , weighting 88.18 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, c-reactive protein increased, gamma-glutamyltransferase increased, white blood cell count increased. During the same period patient was treated with SHINBIT (300 Mg; Frequency Not Provided) (View Shinbit Review and Shinbit Label ), INOVAN (75 Mg; Frequency Not Provided) (View Inovan Review and Inovan Label ). Patient was hospitalized.

6106147-6 | Cardio-respiratory Arrest
on Feb 25, 2009 Male patient from JAPAN , weighting 165.3 lb, was diagnosed with ventricular fibrillation and was treated with Ancaron (View Usage). After Ancaron was administered, patient had the following side effects: cardio-respiratory arrest. Ancaron dosage: 1.25 Mg.ml At 10 Ml/min. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), ALOSENN (View Alosenn Review and Alosenn Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6103485-8 | Acidosis, Cardiogenic Shock, Disseminated Intravascular Coagulation, Liver Disorder
on Feb 24, 2009 Male patient from JAPAN , weighting 123.5 lb, was diagnosed with ventricular tachycardia, congestive cardiomyopathy, atrial flutter, gastritis, hyperuricaemia and was treated with Ancaron (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, cardiogenic shock, disseminated intravascular coagulation, liver disorder. Ancaron dosage: . During the same period patient was treated with BLOPRESS (1 Unit Every 1 Day) (View Blopress Review and Blopress Label ), LASIX (1 Unit Every 1 Day) (View Lasix Review and Lasix Label ), TOUGHMAC E (2 Unit Every 1 Day) (View Toughmac E Review and Toughmac E Label ), WARFARIN SODIUM (1.5 Unit Every 1 Day) (View Warfarin Sodium Review and Warfarin Sodium Label ), TENORMIN (2 Unit Every 1 Day) (View Tenormin Review and Tenormin Label ), GASMOTIN (2 Unit Every 1 Day) (View Gasmotin Review and Gasmotin Label ), ZYLORIC (1 Unit Every 1 Day) (View Zyloric Review and Zyloric Label ).

6082782-9 |
Patient was taking Ancaron (View Usage). on Feb 09, 2009 from JAPAN Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with ventricular fibrillation, cardio-respiratory arrest and. Ancaron dosage: . During the same period patient was treated with ATROPINE (View Atropine Review and Atropine Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).